March 2020 Clinical Watch Newsletter

April 29, 2020

In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug. Lastly, we review claims data for psychotropic polypharmacy in children.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
April 2020 Clinical Watch Newsletter
April 2020 Clinical Watch Newsletter

In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associate...

Next Article
Infographic: How Contact Tracing Works
Infographic: How Contact Tracing Works

To successfully reopen the U.S. economy, public health agencies must perform extensive contact tracing to k...

Explore our Clinical Watch Newsletter

Learn More